These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 26622347)

  • 1. Clinical characteristics and treatment outcome of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Chantaphakul H; Sanon T; Klaewsongkram J
    Exp Ther Med; 2015 Aug; 10(2):519-524. PubMed ID: 26622347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Lerch M; Mainetti C; Terziroli Beretta-Piccoli B; Harr T
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):147-176. PubMed ID: 29188475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of toxic epidermal necrolysis by a multidisciplinary team. A review of literature and treatment results.
    Papp A; Sikora S; Evans M; Song D; Kirchhof M; Miliszewski M; Dutz J
    Burns; 2018 Jun; 44(4):807-815. PubMed ID: 29627131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stevens-johnson Syndrome and Toxic Epidermal Necrolysis: An Overview of Diagnosis, Therapy Options and Prognosis of Patients.
    Garg VK; Buttar HS; Bhat SA; Ainur N; Priya T; Kashyap D; Tuli HS
    Recent Adv Inflamm Allergy Drug Discov; 2023; 17(2):110-120. PubMed ID: 37605396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ophthalmic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Relation to SCORTEN.
    Morales ME; Purdue GF; Verity SM; Arnoldo BD; Blomquist PH
    Am J Ophthalmol; 2010 Oct; 150(4):505-510.e1. PubMed ID: 20619392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose intravenous immunoglobulins in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese patients: a retrospective study of 82 cases.
    Chen J; Wang B; Zeng Y; Xu H
    Eur J Dermatol; 2010; 20(6):743-7. PubMed ID: 20952352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxic epidermal necrolysis and Stevens-Johnson syndrome in South Africa: a 3-year prospective study.
    Kannenberg SM; Jordaan HF; Koegelenberg CF; Von Groote-Bidlingmaier F; Visser WI
    QJM; 2012 Sep; 105(9):839-46. PubMed ID: 22543685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nine years of a single referral center management of Stevens-Johnson syndrome and toxic epidermal necrolysis (Lyell's syndrome).
    Monteiro D; Egipto P; Barbosa J; Horta R; Amarante J; Silva P; Silva A
    Cutan Ocul Toxicol; 2017 Jun; 36(2):163-168. PubMed ID: 27487073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in 87 Japanese patients--Treatment and outcome.
    Yamane Y; Matsukura S; Watanabe Y; Yamaguchi Y; Nakamura K; Kambara T; Ikezawa Z; Aihara M
    Allergol Int; 2016 Jan; 65(1):74-81. PubMed ID: 26666483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in children: 20 years study in a tertiary care hospital.
    Techasatian L; Panombualert S; Uppala R; Jetsrisuparb C
    World J Pediatr; 2017 Jun; 13(3):255-260. PubMed ID: 27650525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving mortality outcomes of Stevens Johnson syndrome/toxic epidermal necrolysis: A regional burns centre experience.
    Nizamoglu M; Ward JA; Frew Q; Gerrish H; Martin N; Shaw A; Barnes D; Shelly O; Philp B; El-Muttardi N; Dziewulski P
    Burns; 2018 May; 44(3):603-611. PubMed ID: 29029855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profile and pattern of Stevens-Johnson syndrome and toxic epidermal necrolysis in a general hospital in Singapore: treatment outcomes.
    Tan SK; Tay YK
    Acta Derm Venereol; 2012 Jan; 92(1):62-6. PubMed ID: 21710108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genitourinary involvement and management in children with Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Van Batavia JP; Chu DI; Long CJ; Jen M; Canning DA; Weiss DA
    J Pediatr Urol; 2017 Oct; 13(5):490.e1-490.e7. PubMed ID: 28314701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Compilation of Drug Etiologies of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Abulatan IT; Ben-David SG; Morales-Colon LA; Beason E; Fakoya AO
    Cureus; 2023 Nov; 15(11):e48728. PubMed ID: 38094551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic kidney disease is potentially an independent prognostic factor for death in Stevens-Johnson syndrome and toxic epidermal necrolysis patients.
    Rattanakaemakorn P; Palakornkitti P; Pinyowiwat P; Jedee P; Thadanipon K
    Front Med (Lausanne); 2022; 9():939210. PubMed ID: 36091688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stevens-Johnson syndrome and toxic epidermal necrolysis: A systematic review of PubMed/MEDLINE case reports from 1980 to 2020.
    Wang L; Varghese S; Bassir F; Lo YC; Ortega CA; Shah S; Blumenthal KG; Phillips EJ; Zhou L
    Front Med (Lausanne); 2022; 9():949520. PubMed ID: 36091694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical value of the prognostic nutritional index and red blood cell distribution width-to-albumin ratio for the prediction of severity of and mortality associated with Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Zhang Z; Yu K; Jiang Z; Liu O; Wan C; Wu H; Cao X
    J Dermatol; 2023 Apr; 50(4):518-524. PubMed ID: 36478458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Harr T; French LE
    Chem Immunol Allergy; 2012; 97():149-66. PubMed ID: 22613860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the Factors Influencing Mortality in Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Multicenter Study of 166 Patients.
    Erduran F; Adışen E; Emre S; Hayran Y; Başkan EB; Yazıcı S; Bilgiç A; Alpsoy E; Günaydın SD; Elmas L; Akyol M; Güner R; Arıca DA; Aypek Y; Ergun T; Karavelioğlu D; Yazıcı AC; Aydoğan K; Bayramgürler D; Kıran R; Erdoğan HK; Acer E; Aktaş A
    Dermatol Ther (Heidelb); 2024 Jun; 14(6):1547-1560. PubMed ID: 38758423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Causative Drugs and Clinical Outcome in Stevens Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), and SJS-TEN Overlap in Children.
    Sethuraman G; Sharma VK; Pahwa P; Khetan P
    Indian J Dermatol; 2012 May; 57(3):199-200. PubMed ID: 22707771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.